Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-24-029603

SVP, Head of Finance & Admin. sold 2,273 shares at $25.85 ($58,757)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Scalzo Richard William · SVP, Head of Finance & Admin.

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-03-07 Sale : show line 1 in the form 10b5-1 −2,273 $25.85 $58,757 121,955 D
Open-market sales · 2,273 sh · avg $25.85 · $58,757
Loading xslF345X05/ownership.xml…